Despite there being a dearth of Australian studies researching vaccine-injured patients, the evidence for Post-COVID-19 Vaccination Syndrome (PCVS, or “Long Vax”) continues to advance in international studies.
In a new study from one of Germany’s top neurological research teams, evidence is presented of auto-antibodies which are responsible for a range of neuropathic symptoms.
The paper states: “Compared with controls, PCVS patients had a significantly greater frequency of autoantibodies against peripheral nervous system structure”.
They go on to say: “[U]ntil now, there are neither diagnostic criteria nor biomarkers available for facilitating the diagnosis of PCVS … we propose to further investigate the biomarker potential and pathophysiological role of autoantibody reactivity in larger groups of PCVS patients.”
The tests they undertook were not run-of-the-mill pathology tests, though they are the type of tests that could be undertaken in any number of Australia’s advanced medical research laboratories. However, to date there has simply been no interest in doing so in Australia.
Read the full paper online at: doi:10.3389/fimmu.2024.1404800
